Virtus Investment Advisers, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 19481 HARTFORD, CT

Position in ARWR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,271,963

+$516,742 QoQ

Shares Held

15,605

+29.6% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#224

of 497 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. ARWR ranks #34 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,544	$3,349,107
2	ALNY	Alnylam Pharmaceuticals, Inc.	9,953	$2,996,151
3	REGN	Regeneron Pharmaceuticals, Inc.	4,320	$2,693,692
4	MRNA	Moderna, Inc.	23,300	$1,631,699
5	RARE	Ultragenyx Pharmaceutical Inc.	47,757	$1,594,606
6	PGEN	Precigen, Inc.	261,322	$1,489,535
7	AGIO	Agios Pharmaceuticals, Inc.	39,473	$1,464,843
8	RYTM	Rhythm Pharmaceuticals, Inc.	13,158	$1,460,932

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,271,963	15,605	+29.6%	Shares	Other	2026-08-11
2026-03-31	$755,221	12,045	+23.6%	Shares	Other	2026-05-14
2025-12-31	$647,236	9,749	+39.0%	Shares	Other	2026-02-17
2025-09-30	$241,947	7,015	+21.0%	Shares	Other	2025-11-14
2025-06-30	$91,592	5,797	-21.8%	Shares	Other	2025-08-13
2025-03-31	$94,467	7,415	+36.5%	Shares	Other	2025-05-15
2023-06-30	$193,740	5,433	0.0%	Shares	Other	2023-08-14
2023-03-31	$137,998	5,433	-3.8%	Shares	Other	2023-05-15
2022-12-31	$228,961	5,645	0.0%	Shares	Other	2023-02-14
2022-09-30	$186,567	5,645	—	Shares	Other	2022-11-14
No filing history on record for this holder in this stock.